Anne S R van Lindert

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Chronic Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Small Cell Lung Cancer

Bioinformatics Analysis

Top Venues

Cancer immunology, immunotherapy : CII

Journal of cachexia, sarcopenia and muscle

This page only lists publications with an associated author ORCID identifier.

Publications

Mick J M van Eijs, Rik J Verheijden, Stefanie A van der Wees, Stefan Nierkens, Anne S R van Lindert, Karlijn P M Suijkerbuijk, Femke Van Wijk, null null
Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition. Cancer immunology, immunotherapy : CII (2023)
Mick J M van Eijs, Lotte E van der Wagen, Rogier Mous, Roos J Leguit, Lisette van de Corput, Anne S R van Lindert, Britt B M Suelmann, Anna M Kamphuis, Stefan Nierkens, Karlijn P M Suijkerbuijk
Hematologic malignancies following immune checkpoint inhibition for solid tumors. Cancer immunology, immunotherapy : CII (2022)
Corine de Jong, Najiba Chargi, Gerarda J M Herder, Simone W A van Haarlem, Femke van der Meer, Anne S R van Lindert, Alexandra Ten Heuvel, Jan Brouwer, Pim A de Jong, Lot A Devriese, Alwin D R Huitema, Antoine C G Egberts, Remco de Bree, Vera H M Deneer
The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients. Journal of cachexia, sarcopenia and muscle 13 (3) (2022)